Researchers are investigating genetic variants in GLP-1 receptor pathways, gut microbiome profiles, and baseline hormone levels to determine who will respond best to GLP-1 therapy, who might benefit from dual agonists, and who is more prone to side effects
Investigations assess its potential effects on cuprizone-associated demyelination, traumatic brain injury, neurotoxin-induced dopaminergic disruption, neurotransmitter regulation, and peripheral or central nerve regeneration
Nature 503 , 267271 (2013)
Cholesterol and diabetes
A: For GLP-1 medications, follow-ups are recommended at 1-month intervals until you have reached a steady state, at which time you will meet with your provider every 3 months
The last organic form is methylselenocysteine (aka Se-methylselenocysteine)